reference/25667979

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25667979

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study
endingPage	980
issn	1083-7159 1549-490X
issueIdentifier	8
pageRange	974-980
publicationName	The Oncologist
startingPage	974
bibliographicCitation	Kazandjian D, Blumenthal GM, Luo L, He K, Fran I, Lemery S, Pazdur R. Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer. Oncologist. 2016 Aug;21(8):974–80. PMID: 27328934; PMCID: PMC4978556.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf2497eaf215c125fcc4d21be30bb608 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a58da0f3b7a4dd9e0049f85b1260b1f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2670f42c2b172f2d8821bf8a4673ecef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff201c0eb2f137efe87a75d59eaa4af5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1f7ae4e0b90a6d2f53a23f368204286 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a89effe7f2d67f3de4b238eecd50a397 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17a1eba29fdc2198b1d9a40afd6e2fda
date	2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1634/theoncologist.2016-0101 https://pubmed.ncbi.nlm.nih.gov/PMC4978556 https://pubmed.ncbi.nlm.nih.gov/27328934
isPartOf	https://portal.issn.org/resource/ISSN/1083-7159 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21392 https://portal.issn.org/resource/ISSN/1549-490X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer
discusses	http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0553416 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0172583
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011505Q000235 http://id.nlm.nih.gov/mesh/D011720Q000008 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D047428Q000008 http://id.nlm.nih.gov/mesh/D011518Q000235 http://id.nlm.nih.gov/mesh/D011725Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015321 http://id.nlm.nih.gov/mesh/D000077547 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D011720Q000009 http://id.nlm.nih.gov/mesh/D047428Q000009 http://id.nlm.nih.gov/mesh/D011725Q000009 http://id.nlm.nih.gov/mesh/D014486 http://id.nlm.nih.gov/mesh/D014481 http://id.nlm.nih.gov/mesh/D018570 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D002289Q000235 http://id.nlm.nih.gov/mesh/D009362
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7333 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7548 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11626560 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10064 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4e826c880e43b7ad8008a5acf74ab07b

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6098

Total number of triples: 76.